XWELL (XWEL) 3-Year Revenue Growth Rate : 24.20% (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is XWELL 3-Year Revenue Growth Rate?

XWELL's Revenue per Share for the three months ended in Dec. 2023 was $1.77.

During the past 12 months, XWELL's average Revenue per Share Growth Rate was -39.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 24.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was -66.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was -38.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of XWELL was 1509.10% per year. The lowest was -88.60% per year. And the median was 9.05% per year.

Competitive Comparison of XWELL's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, XWELL's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XWELL's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, XWELL's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where XWELL's 3-Year Revenue Growth Rate falls into.

XWELL 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

XWELL (NAS:XWEL) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

XWELL 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of XWELL's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

XWELL (XWEL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » XWELL Inc (NAS:XWEL) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

254 West 31st Street, 11th Floor, New York, NY, USA, 10001

Website

https://www.xwell.com

XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresCheck, XpresSpa, Treat, and HyperPointe. XpresSpa is an airport retailer of wellness services and related products. Treat is a travel health and wellness brand that offers in-airport spa and wellness medical services. XpresCheck provides Covid-19 screening and diagnostic testing in partnership with the CDC. HyperPointe is a digital healthcare and data analytics relationship company.

Executives

Suzanne A. Scrabis	officer: Chief Financial Officer	C/O XWELL, INC., 254 WEST 31ST STREET, 11TH FLOOR, NEW YORK NY 10001
Robert Weinstein	director	3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS NV 89169
Scott R Milford	officer: Chief Executive Officer	C/O TOWN SPORTS INTERNATIONAL, LLC, 5 PENN PLAZA, NEW YORK NY 10001
Bruce Bernstein	director	780 THIRD AVENUE, 12TH FLOOR, NEW YORK NY 10017
Ezra Ernst	officer: See Remarks	C/O XPRESSPA GROUP, INC., 254 WEST 31ST STREET, 11TH FLOOR, NEW YORK NY 10001
Omar Haynes	officer: VP Treas & Fi & Interim CFO	C/O XPRESSPA GROUP, INC., 254 WEST 31ST STREET, 11TH FLOOR, NEW YORK NY 10001
Doug Satzman	director, officer: Chief Executive Officer	780 THIRD AVENUE, 12TH FLOOR, NEW YORK NY 10017
James A. Berry	officer: Chief Financial Officer	C/O XPRESSPA GROUP, INC., 254 WEST 31ST STREET, 11TH FLOOR, NEW YORK NY 10001
Michael Lebowitz	director	780 THIRD AVENUE, 12TH FLOOR, C/O XPRESSPA GROUP, INC., NEW YORK NY 10017
Donald E. Stout	director	780 THIRD AVENUE, 15TH FLOOR, NEW YORK NY 10017
Mistral Spa Holdings, Llc	10 percent owner	C/O MISTRAL CAPITAL MANAGEMENT, LLC, 650 FIFTH AVENUE, 31ST FLOOR, NEW YORK NY 10019
Mistral Capital Management, Llc	10 percent owner	650 FIFTH AVENUE, 31ST FLOOR, NEW YORK NY 10019
Andrew R Heyer	other: Former director and 10% owner	501 MADISON AVENUE, FLOOR 5, NEW YORK NY 10019
Calm.com, Inc.	10 percent owner	140 2ND STREET, THIRD FLOOR, SAN FRANCISCO CA 94105
Edward Jankowski	officer: SVP; CEO of XpresSpa	C/O FORM HOLDINGS CORP., 780 THIRD AVENUE, 12TH FLOOR, NEW YORK NY 10017